RETINA CHANGES IN DIABETES: MORPHOLOGICAL, MICROANGIOPATHIC AND MOLECULAR MECHANISMS AND BIOCHEMICAL SIGNIFICANCE OF USED DRUGS

Authors

  • Jumayev Shahzodbek, Norboyev Davlatjon 2nd year student of the Faculty of Medicine No. 2 of Tashkent State Medical University,2nd year student of the Faculty of Medicine No. 2 of Tashkent State Medical University

Keywords:

diabetes; diabetic retinopathy; retina; microangiopathy; pericytes; capillary basement membrane; oxidative stress; advanced glycation end products (AGE); protein kinase C (PKC); VEGF; neovascularization; diabetic macular edema; anti-VEGF drugs; microcirculation.

Abstract

Diabetes mellitus (DM) is a chronic metabolic disease , one of the most severe and clinically significant complications of which is diabetic retinopathy. This article comprehensively analyzes the morphological, microangiopathic and molecular changes that occur in the retina of the eye in diabetes. The role of thickening of the basement membrane of retinal capillaries, selective loss of pericytes, endothelial dysfunction, capillary occlusion, ischemia and hypoxia in the pathogenesis is highlighted. Also, the mechanisms of pathological neovascularization caused by oxidative stress, glucose polyol pathway, advanced glycation end products (AGE), protein kinase C (PKC) activation, and VEGF were scientifically described. The article analyzes the biochemical mechanisms of action of anti-VEGF drugs, corticosteroids, antioxidant and angioprotective drugs used in the treatment of diabetic retinopathy, and shows their importance in improving retinal microcirculation and slowing disease progression. The obtained data serve as a scientific basis for early diagnosis of diabetic retinopathy, pathogenesis-oriented therapy , and improvement of preventive approaches.

Downloads

Download data is not yet available.

References

Ashton N. Diabetic retinopathy. British Journal of Ophthalmology . 1960;44(2):65–80.

Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes . 2005;54(6):1615–1625.

Aiello LP. Angiogenic pathways in diabetic retinopathy. New England Journal of Medicine. 2005;353(8):839–841.

Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. New England Journal of Medicine. 2012;366(13):1227–1239.

Kern TS, Engerman RL. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia. Archives of Ophthalmology. 1996;114(3):306–310.

Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–1682.

Brown DM, Nguyen QD, Marcus DM, et al. Ranibizumab versus sham for diabetic macular edema. Ophthalmology. 2013;120(10):2013–2022.

Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. The Lancet. 2010;376(9735):124–136.

Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy. Progress in Retinal and Eye Research. 2016;51:156–186.

Downloads

Published

2026-05-04

How to Cite

Jumayev Shahzodbek, Norboyev Davlatjon. (2026). RETINA CHANGES IN DIABETES: MORPHOLOGICAL, MICROANGIOPATHIC AND MOLECULAR MECHANISMS AND BIOCHEMICAL SIGNIFICANCE OF USED DRUGS. Journal of Applied Science and Social Science, 16(5), 123–126. Retrieved from https://www.internationaljournal.co.in/index.php/jasass/article/view/4274

Issue

Vol. 16 No. 5 (2026): Journal of Applied Science and Social Science

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in the Journal of Applied Science and Social Science (JASSS) is protected by copyright. Authors retain the copyright to their work, and grant JASSS the right to publish the work under a Creative Commons Attribution License (CC BY). This license allows others to distribute, remix, adapt, and build upon the work, even commercially, as long as they credit the author(s) for the original creation.